JP Morgan Maintains Neutral on HCA Healthcare, Raises Price Target to $332
HCA Holdings, Inc. -0.63%
HCA Holdings, Inc. HCA | 408.17 | -0.63% |
JP Morgan analyst Lisa Gill maintains HCA Healthcare (NYSE:
HCA) with a Neutral and raises the price target from $327 to $332.